Leap therapeutics, inc. reports earnings results for the third quarter ended september 30, 2019

Leap therapeutics, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 7.923 million compared to usd 8.599 million a year ago. net loss was usd 7.935 million compared to usd 6.632 million a year ago. basic loss per share was usd 0.33 compared to usd 0.45 a year ago. diluted loss per share was usd 0.33 compared to usd 0.55 a year ago. for the nine months, operating loss was usd 25.179 million compared to usd 21.780 million a year ago. net loss was usd 24.904 million compared to usd 24.618 million a year ago. basic loss per share was usd 1.15 compared to usd 1.76 a year ago.
LPTX Ratings Summary
LPTX Quant Ranking